Cilazapril monohydrate

Biochem/physiol Actions 5-HT 4 serotonin receptor agonist. Features and Benefits This compound was developed by Johnson &amp Johnson .

Biochem/physiol Actions 5-HT 4 serotonin receptor agonist. Features and Benefits This compound was developed by Johnson &amp Johnson .

Cyclophosphamide monohydrate is an alkylating, antineoplastic agent, which is converted in the body to an active alkylating metabolite (4-hydroxycyclophosphamide). It possesses immunosuppressant properties.

Cyclophosphamide monohydrate is an alkylating, antineoplastic agent, which is converted in the body to an active alkylating metabolite (4-hydroxycyclophosphamide). It possesses immunosuppressant properties.

Cyclophosphamide monohydrate is an alkylating, antineoplastic agent, which is converted in the body to an active alkylating metabolite (4-hydroxycyclophosphamide). It possesses immunosuppressant properties.

Citric acid is a key metabolic intermediate. Citrate is the starting point of the tricarboxylic acid cycle.

Citric acid is a key metabolic intermediate. Citrate is the starting point of the tricarboxylic acid cycle.

Sodium citrate, dihydrate, cas 6132-04-3, item 800. Sodium nitrate is a sodium salt of citric acid.

Sodium citrate, dihydrate, cas 6132-04-3, item 800. Sodium nitrate is a sodium salt of citric acid.